Biogen to Pay $900M to Settle Physician Kickback Allegations
Former employee/whistleblower to receive $250 million as part of settlement involving three drugs used to treat muscular sclerosis.
Stay updated with breaking news from Multiple Sclerosis Ms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Former employee/whistleblower to receive $250 million as part of settlement involving three drugs used to treat muscular sclerosis.
Aerobic exercise has the potential to restore function in adults with MS and thalamic atrophy — a patient population at increased risk for progressive physical and cognitive decline.
The top 3 things you should know to start your day.
Ublituximab is superior to teriflunomide in suppressing multiple sclerosis relapses and lesions on MRI, suggest findings from the phase 3 ULTIMATE I and II trials.
New research suggests healthcare spending as an alternative to the "latitude hypothesis" to better explain the higher prevalence of multiple sclerosis found in countries far from the equator.